STOCK TITAN

SCIENTIFIC INDUSTRIES INC Form 4 Filings

SCND OTC

Every Form 4 that SCIENTIFIC INDUSTRIES INC (SCND) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow SCND and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SCND filings page.

Rhea-AI Summary

SCIENTIFIC INDUSTRIES INC (SCND) reported that Chairman of the Board and director John A. Moore purchased 5,000 shares of Common Stock on August 20, 2026 at $0.76 per share in a purchase described as an open-market or private transaction. Following this transaction, he directly holds 950,641 shares.

Rhea-AI Summary

SCIENTIFIC INDUSTRIES INC (SCND) reported an insider share purchase by Chairman of the Board John A. Moore. On 2026-08-20, he purchased 14,700 shares of Common Stock in an open market or private transaction at $0.7112 per share, bringing his directly held stake to 945,641 shares.

Rhea-AI Summary

Scientific Industries Inc. Chairman of the Board and director John A. Moore bought 4,000 shares of Common Stock in an open-market purchase at $0.7113 per share. After this transaction, he directly holds 930,871 shares, making this a relatively small addition to his existing position.

Rhea-AI Summary

Scientific Industries Inc. reported that President and CEO Helena R. Santos received a grant of stock options covering 130,000 shares of common stock on February 17, 2026. The options have an exercise price of $0.60 per share, were granted at no purchase cost, and vest on a 4 year cliff from the grant date. Following this award, Santos holds options on a total of 563,388 shares directly. This is a compensation-related grant rather than an open-market share purchase or sale.

Rhea-AI Summary

Scientific Industries Inc. reported that President and CEO Helena R. Santos received a grant of stock options to acquire 50,000 shares of common stock. The options carry an exercise price of $0.60 per share, become exercisable starting on February 17, 2027, and expire on February 17, 2036. According to the disclosure, these options were granted in lieu of salary and vest over one year at a rate of 1/12th per month. After this grant, Santos directly holds 433,388 derivative securities related to the company.

Rhea-AI Summary

SCIENTIFIC INDUSTRIES INC Chairman John A. Moore bought additional shares of the company’s stock. On this Form 4, he reports an open-market purchase of 9,000 shares of Common Stock at a price of $0.58 per share on March 23, 2026.

Following this transaction, Moore directly owns 926,871 shares of Scientific Industries common stock. This filing reflects a net increase in his holdings, as there were no reported sales, option exercises, or derivative transactions in this disclosure.

Rhea-AI Summary

Scientific Industries Inc. reported a stock option grant to its Chief Financial Officer, Zachary Rovinsky. He received options for 25,000 shares of common stock at an exercise price of $0.6000 per share. These options vest on a 4-year cliff from the grant date, meaning none vest until the four-year mark, when they vest in full.

After this award, he holds a total of 45,000 stock options directly. This is a compensation-related, non-market transaction rather than an open-market purchase or sale of common shares.

Rhea-AI Summary

Scientific Industries Inc. director Michael Blechman received grants of stock options covering a total of 44,000 shares of common stock on February 17, 2026. The awards consist of 24,000 and 20,000 option shares, each with an exercise price of 0.6000 and expiration on February 17, 2036.

The options were granted in lieu of cash director fees and vest over one year at 1/12 per month, providing compensation rather than reflecting open-market buying. Following these grants, Blechman directly holds 116,186 stock options linked to the company’s common stock.

Rhea-AI Summary

SCIENTIFIC INDUSTRIES INC Chairman of the Board and director John A. Moore made an open-market purchase of the company’s common stock. He bought 1,000 shares on February 19, 2026 at a price of $0.65 per share. Following this transaction, Moore directly owns 917,871 common shares of Scientific Industries.

Rhea-AI Summary

Scientific Industries Inc. director and chairman John A. Moore received stock option awards as compensation. He was granted stock options covering 230,000 shares of common stock and an additional 30,000-share option, each with a conversion price of $0.6000 per share.

The filing shows these awards were granted in lieu of cash compensation and vest over one year at a rate of 1/12 per month. Following these grants, Moore holds stock options covering 916,871 shares, giving him additional long-term equity exposure but reflecting routine, compensation-related awards rather than open-market purchases.

Rhea-AI Summary

Scientific Industries Inc. director John J. Nicols received stock options as compensation instead of cash fees. On February 17, 2026, he was granted stock options covering a total of 140,000 shares of Common Stock, with an exercise price of $0.60 per share and an expiration date of February 17, 2036.

The options vest over one year at a rate of 1/12 per month. Following these awards, Nicols holds 275,778 stock options in total, reflecting routine equity-based director compensation rather than open‑market trading.

Rhea-AI Summary

Scientific Industries Inc. director and chairman John Moore reported an insider purchase of 6,500 shares of the company’s common stock on 12/17/2025 at a price of $0.5315 per share. This open-market transaction, disclosed on a Form 4, increased his direct holdings to 663,371 shares of Scientific Industries common stock.

Rhea-AI Summary

SCIENTIFIC INDUSTRIES INC chairman and director John Moore acquired 11,700 shares of common stock on 12/17/2025 at $0.5435 per share. After this purchase, he directly owns 656,871 shares of the company’s stock.

Rhea-AI Summary

Scientific Industries Inc (SCND) reported that chairman and director John Moore acquired 20,000 shares of common stock on 12/05/2025 at $0.6048 per share. Following this purchase, he directly owns 645,171 shares, giving him a larger personal stake in the company.

Rhea-AI Summary

Scientific Industries, Inc. (SCND) reporting person John J. Nicols, a director, exercised 15,000 warrants on 08/20/2025 at an exercise price of $1.00 per share. The exercise converted the warrants into 15,000 shares of common stock, increasing the reporting person's total beneficial ownership to 90,778 shares. The filing indicates the transaction was a direct acquisition and does not disclose any concurrent sale of the shares. The signed Form 4 was dated 10/06/2025.

Rhea-AI Summary

John A. Moore, Chairman and Director of Scientific Industries Inc. (SCND), reported a personal purchase of 5,800 shares of the company's common stock on 09/17/2025 at a price of $0.70 per share. After the transaction he beneficially owned 467,089 shares. The Form 4 was signed by John Moore on 09/18/2025 and was filed as a single reporting person disclosure.

Rhea-AI Summary

Director John A. Moore purchased 9,599 shares of Scientific Industries Inc. (SCND) on 09/16/2025 at $0.64 per share. After the transaction he beneficially owns 461,289 shares. The Form 4 indicates the filing was signed on 09/18/2025 and identifies Moore as a company director. No derivative transactions or other securities changes are reported.